Second Generation of Drug Candidates Show in Vitro Efficacy Against Leishmaniasis and Trypanosomiasis
VANCOUVER, BC -- (Marketwire) -- 10/07/08 -- Upstream Biosciences Inc. (OTCBB:...
Company reaches a significant development milestone in program to treat Trypanosomiasis
Vancouver, British Columbia CANADA, September 15, 2008 /FSC/ -
Upstream Biosciences...
Dr.
Hide's Expertise Spans Bioinformatics, Computational Genomics, Drug
Discovery and Tropical Diseases and Includes Distinguished Positions in
Academia, the Public Sector and Industry
...
Results
of In Vitro Efficacy Tests Indicate That Upstream's Initial
Anti-Malaria Drug Candidates Have Activity in the Nanomolar Range
Upstream Biosciences Inc. (OTCBB: UPBS) today...
MSU's
Prestigious Chemistry Department Has Agreed to Apply Its Combinatorial
Chemistry Expertise to Synthesize Compounds for Upstream's Drug
Discovery and Development Efforts
...
In
Vitro Testing Collaboration With the Provincial Laboratory for Public
Health Marks the Formal Initiation of Upstream's Preclinical
Anti-Malaria Program
Upstream Biosciences...
Uganda's Prestigious "Harvard of Africa" Will Conduct the First Tests in Animals of Upstream's Novel Agents for Trypanosomiasis
Upstream Biosciences Inc. (OTCBB: UPBS) today
...
#29: Upstream Biosciences and Government of Uganda Sign Letter of Intent to Collaborate on Development of Novel Agents to Treat Tropical Parasitic Diseases
Represents First of Expected Multiple Collaborations Intended to Accelerate the Development and Commercialization of Upstream's Promising Drug CandidatesUpstream Biosciences Inc. (OTCBB:...
Keynote Address to Highlight Upstream's Drug Candidates That Have Demonstrated Promising In Vitro Activity Against "Sleeping Sickness" and Other Parasitic Diseases; Need for Improved...
Acquisition of Pacific Pharma Technologies Brings Proprietary Artificial Intelligence-Based Drug Discovery Platform and Novel Drug Candidates to Upstream
Initial Compounds Demonstrate...
-Acquisition of Pacific Pharma Technologies Brings Proprietary Artificial Intelligence-Based Drug Discovery Platform and Novel Drug Candidates to Upstream-
-Initial Compounds Demonstrate...
Agreement Will Support Development of BioMarkers for Liver and Prostate CancerUpstream Biosciences Inc. (OTCBB: UPBS), today announced it has signed an agreement with Analytical...
Upstream Biosciences’ management team has over thirty years of combined experience in the biotech sector. The CEO and Co-founder of the company, Joel Bellenson, previously served as the CEO of a...
Upstream Biosciences Inc. (OTCBB: UPBS Forumstocks) ("Upstream" or "the Company"), an emerging leader in the field of genetic diagnostics for cancer and the prediction of drug response, announces a...
